Professional Documents
Culture Documents
macrophages present in several types of inflammatory conditions. Special attention is being given to minimizing the use of animal testing by establishing adequate in vitro models. The newly produced FR mAb proved invaluable for development of the immunoprecipitation protocol that is suitable for mass spectrometry analysis. Recombinant Fab fragments are being produced in order to facilitate the production of the final bispecific antibody to be used in the surface of the FBN.
www.nanofol.eu Partners
Suanfarma SA Spain Technische Universitaet Graz Austria Nederlandse Organisatie Voor Toegepast Natuurwetenschappelijk Onderzoek Netherlands Instituto de Biologia Molecular e Celular Portugal Institut National de la Sant et de la Recherche Mdicale France Medizinische Universitaet Wien Austria Aurel Vlaicu University of Arad Romania Synovo GmbH Germany Institut National de lEnvironnement et des risques France Exbio Praha AS Czech Republic ALMA Consulting Group SAS France ALFAMA Investigacao e Desenvolvimento de Produtos Farmaceuticos, Lda Portugal
Acknowledgements
The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement n NMP4-LA-2009-228827 NANOFOL.